Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy and is associated with several maternal and neonatal complications (1). Although a number of factors are associated with an increased risk of GDM, including older age, increased weight, personal history of GDM, family history of diabetes, and particular ethnic origins, robust evidence relating to the prevalence of GDM is lacking (2). Worldwide, reported prevalence rates of GDM have ranged from 1 to 14% (3). This is due to the range of different definitions and diagnostic test criteria that are used, as well as variations across regions and ethnic groups (4). Nonetheless, it is widely accepted that GDM affects a significant number of pregnancies worldwide and that prevalence levels have been increasing rapidly in recent years (1). As a result, strategies to identify and treat GDM are being implemented in many countries, including Ireland, where O'Sullivan et al. 